| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-09 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-09 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-08 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-07 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0009 |
| mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0009 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0009 |